These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 10412745)

  • 1. Effect of simvastatin on proliferative nephritis and cell-cycle protein expression.
    Yoshimura A; Nemoto T; Sugenoya Y; Inui K; Watanabe S; Inoue Y; Sharif S; Yokota N; Uda S; Morita H; Ideura T
    Kidney Int Suppl; 1999 Jul; 71():S84-7. PubMed ID: 10412745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simvastatin suppresses glomerular cell proliferation and macrophage infiltration in rats with mesangial proliferative nephritis.
    Yoshimura A; Inui K; Nemoto T; Uda S; Sugenoya Y; Watanabe S; Yokota N; Taira T; Iwasaki S; Ideura T
    J Am Soc Nephrol; 1998 Nov; 9(11):2027-39. PubMed ID: 9808088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct inhibitory effects of simvastatin on matrix accumulation in cultured murine mesangial cells.
    Nogaki F; Muso E; Yashiro M; Kasuno K; Kamata T; Ono T; Sasayama S
    Kidney Int Suppl; 1999 Jul; 71():S198-201. PubMed ID: 10412775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis.
    Chen YM; Chien CT; Hu-Tsai MI; Wu KD; Tsai CC; Wu MS; Tsai TJ
    Kidney Int; 1999 Sep; 56(3):932-43. PubMed ID: 10469361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of experimental mesangial proliferative nephritis by interferon-gamma.
    Johnson RJ; Lombardi D; Eng E; Gordon K; Alpers CE; Pritzl P; Floege J; Young B; Pippin J; Couser WG
    Kidney Int; 1995 Jan; 47(1):62-9. PubMed ID: 7731171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PDGF signal transduction inhibition ameliorates experimental mesangial proliferative glomerulonephritis.
    Gilbert RE; Kelly DJ; McKay T; Chadban S; Hill PA; Cooper ME; Atkins RC; Nikolic-Paterson DJ
    Kidney Int; 2001 Apr; 59(4):1324-32. PubMed ID: 11260393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-type natriuretic peptide inhibits mesangial cell proliferation and matrix accumulation in vivo.
    Canaan-Kühl S; Ostendorf T; Zander K; Koch KM; Floege J
    Kidney Int; 1998 May; 53(5):1143-51. PubMed ID: 9573528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenomedullin reduces mesangial cell number and glomerular inflammation in experimental mesangioproliferative glomerulonephritis.
    Plank C; Hartner A; Klanke B; Geissler B; Porst M; Amann K; Hilgers KF; Rascher W; Dötsch J
    Kidney Int; 2005 Sep; 68(3):1086-95. PubMed ID: 16105039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 1,25(OH)2D3 in experimental mesangial proliferative nephritis in rats.
    Panichi V; Migliori M; Taccola D; Filippi C; De Nisco L; Giovannini L; Palla R; Tetta C; Camussi G
    Kidney Int; 2001 Jul; 60(1):87-95. PubMed ID: 11422740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [FTY720 attenuates rat anti-Thy-1 mesangial proliferative glomerulonephritis by inhibition of transforming growth factor β1-connective tissue growth factor pathway].
    Jiang JY; Huang XD; Wang Y; Deng AP; Zhou JH
    Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):107-11. PubMed ID: 22455887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P2 receptor antagonist PPADS inhibits mesangial cell proliferation in experimental mesangial proliferative glomerulonephritis.
    Rost S; Daniel C; Schulze-Lohoff E; Bäumert HG; Lambrecht G; Hugo C
    Kidney Int; 2002 Nov; 62(5):1659-71. PubMed ID: 12371966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-10 inhibits experimental mesangial proliferative glomerulonephritis.
    Kitching AR; Katerelos M; Mudge SJ; Tipping PG; Power DA; Holdsworth SR
    Clin Exp Immunol; 2002 Apr; 128(1):36-43. PubMed ID: 11982588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-glycoside of Tripterygium wilfordii Hook f. ameliorates proteinuria and acute mesangial injury induced by anti-Thy1.1 monoclonal antibody.
    Wan Y; Gu L; Suzuki K; Karasawa T; Fujioka Y; Han GD; Koike H; Kawachi H; Shimizu F
    Nephron Exp Nephrol; 2005; 99(4):e121-9. PubMed ID: 15722645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin suppresses mesangial cell proliferation and matrix expansion in experimental mesangioproliferative glomerulonephritis.
    Floege J; Eng E; Young BA; Couser WG; Johnson RJ
    Kidney Int; 1993 Feb; 43(2):369-80. PubMed ID: 8441232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in cell-cycle protein expression during experimental mesangial proliferative glomerulonephritis.
    Shankland SJ; Hugo C; Coats SR; Nangaku M; Pichler RH; Gordon KL; Pippin J; Roberts JM; Couser WG; Johnson RJ
    Kidney Int; 1996 Oct; 50(4):1230-9. PubMed ID: 8887282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II receptor blockade inhibits acute glomerular injuries with the alteration of receptor expression.
    Mii A; Shimizu A; Masuda Y; Ishizaki M; Kawachi H; Iino Y; Katayama Y; Fukuda Y
    Lab Invest; 2009 Feb; 89(2):164-77. PubMed ID: 19139720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress in the pathogenesis of experimental mesangial proliferative glomerulonephritis.
    Budisavljevic MN; Hodge L; Barber K; Fulmer JR; Durazo-Arvizu RA; Self SE; Kuhlmann M; Raymond JR; Greene EL
    Am J Physiol Renal Physiol; 2003 Dec; 285(6):F1138-48. PubMed ID: 14600028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of interleukin-1 in mesangial cell proliferation and matrix deposition in experimental mesangioproliferative nephritis.
    Tesch GH; Lan HY; Atkins RC; Nikolic-Paterson DJ
    Am J Pathol; 1997 Jul; 151(1):141-50. PubMed ID: 9212740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of lipids on the pathogenesis of progressive renal failure: role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in the prevention of glomerulosclerosis.
    Guijarro C; Keane WF
    Miner Electrolyte Metab; 1996; 22(1-3):147-52. PubMed ID: 8676808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/ p21 signaling pathway: Implications for diabetic nephropathy.
    Danesh FR; Sadeghi MM; Amro N; Philips C; Zeng L; Lin S; Sahai A; Kanwar YS
    Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8301-5. PubMed ID: 12048257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.